Literature DB >> 11274363

Role of MEKK2-MEK5 in the regulation of TNF-alpha gene expression and MEKK2-MKK7 in the activation of c-Jun N-terminal kinase in mast cells.

K Chayama1, P J Papst, T P Garrington, J C Pratt, T Ishizuka, S Webb, S Ganiatsas, L I Zon, W Sun, G L Johnson, E W Gelfand.   

Abstract

Cross-linking of the high-affinity IgE receptor (FcepsilonRI) on mast cells with IgE and multivalent antigen triggers mitogen-activated protein (MAP) kinase activation and cytokine gene expression. We report here that MAP kinase kinase 4 (MKK4) gene disruption does not affect either MAP kinase activation or cytokine gene expression in response to cross-linking of FcepsilonRI in embryonic stem cell-derived mast cells. MKK7 is activated in response to cross-linking of FcepsilonRI, and this activation is inhibited by MAP/ERK kinase (MEK) kinase 2 (MEKK2) gene disruption. In addition, expression of kinase-inactive MKK7 in the murine mast cell line MC/9 inhibits c-Jun NH(2)-terminal kinase (JNK) activation in response to cross-linking of FcepsilonRI, whereas expression of kinase-inactive MKK4 does not affect JNK activation by this stimulus. However, FcepsilonRI-induced activation of the tumor necrosis factor-alpha (TNF-alpha) gene promoter is not affected by expression of kinase-inactive MKK7. We describe an alternative pathway by which MEKK2 activates MEK5 and big MAP kinase1/extracellular signal-regulated kinase 5 in addition to MKK7 and JNK, and interruption of this pathway inhibits TNF-alpha promoter activation. These findings suggest that JNK activation by antigen cross-linking is dependent on the MEKK2-MKK7 pathway, and cytokine production in mast cells is regulated in part by the signaling complex MEKK2-MEK5-ERK5.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274363      PMCID: PMC31880          DOI: 10.1073/pnas.081021898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Mitogen-activated protein kinase pathways.

Authors:  M J Robinson; M H Cobb
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

2.  Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity.

Authors:  D Yang; C Tournier; M Wysk; H T Lu; J Xu; R J Davis; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

3.  Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3.

Authors:  H Nishina; K D Fischer; L Radvanyi; A Shahinian; R Hakem; E A Rubie; A Bernstein; T W Mak; J R Woodgett; J M Penninger
Journal:  Nature       Date:  1997-01-23       Impact factor: 49.962

4.  Aggregation of the FcepsilonRI on mast cells stimulates c-Jun amino-terminal kinase activity. A response inhibited by wortmannin.

Authors:  T Ishizuka; A Oshiba; N Sakata; N Terada; G L Johnson; E W Gelfand
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

5.  Primary structure of BMK1: a new mammalian map kinase.

Authors:  J D Lee; R J Ulevitch; J Han
Journal:  Biochem Biophys Res Commun       Date:  1995-08-15       Impact factor: 3.575

6.  Components of a new human protein kinase signal transduction pathway.

Authors:  G Zhou; Z Q Bao; J E Dixon
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

7.  Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp.

Authors:  E Y Tsai; J Jain; P A Pesavento; A Rao; A E Goldfeld
Journal:  Mol Cell Biol       Date:  1996-02       Impact factor: 4.272

8.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors.

Authors:  H Karasuyama; F Melchers
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

9.  Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice.

Authors:  A Oshiba; E Hamelmann; K Takeda; K L Bradley; J E Loader; G L Larsen; E W Gelfand
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

10.  Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors.

Authors:  J F Martin; J J Schwarz; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

View more
  23 in total

1.  MEKK3 is essential for lipopolysaccharide-induced interleukin-6 and granulocyte-macrophage colony-stimulating factor production in macrophages.

Authors:  Kihwan Kim; Omar Duramad; Xiao-Feng Qin; Bing Su
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

Review 2.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

3.  Hepatitis B virus X protein promotes hepatoma cell proliferation via upregulation of MEKK2.

Authors:  Guang-yao Kong; Jun-ping Zhang; Shuai Zhang; Chang-liang Shan; Li-hong Ye; Xiao-dong Zhang
Journal:  Acta Pharmacol Sin       Date:  2011-08-01       Impact factor: 6.150

4.  MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src.

Authors:  Weiyong Sun; Xudong Wei; Kamala Kesavan; Timothy P Garrington; Ruihua Fan; Junjie Mei; Steven M Anderson; Erwin W Gelfand; Gary L Johnson
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

5.  Cyclic AMP selectively uncouples mitogen-activated protein kinase cascades from activating signals.

Authors:  Gray W Pearson; Svetlana Earnest; Melanie H Cobb
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

6.  Implication of serum IgE in childhood nephrotic syndrome.

Authors:  You-Lin Tain; Tsung-Yi Chen; Kuender D Yang
Journal:  Pediatr Nephrol       Date:  2003-10-31       Impact factor: 3.714

7.  Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.

Authors:  Debasish Maiti; Zhenhua Xu; Elia J Duh
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-30       Impact factor: 4.799

8.  IFN-γ-inducible antiviral responses require ULK1-mediated activation of MLK3 and ERK5.

Authors:  Diana Saleiro; Gavin T Blyth; Ewa M Kosciuczuk; Patrick A Ozark; Beata Majchrzak-Kita; Ahmet D Arslan; Mariafausta Fischietti; Neha K Reddy; Curt M Horvath; Roger J Davis; Eleanor N Fish; Leonidas C Platanias
Journal:  Sci Signal       Date:  2018-11-20       Impact factor: 8.192

9.  Noncanonical function of MEKK2 and MEK5 PB1 domains for coordinated extracellular signal-regulated kinase 5 and c-Jun N-terminal kinase signaling.

Authors:  Kazuhiro Nakamura; Gary L Johnson
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

10.  MEKK2 kinase association with 14-3-3 protein regulates activation of c-Jun N-terminal kinase.

Authors:  Adi E Matitau; Timothy V Gabor; R Montgomery Gill; Michael P Scheid
Journal:  J Biol Chem       Date:  2013-08-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.